"...New York City medical examiner Laurie Montgomery returns to work at the Office of Chief Medical Examiner, where she's been employed for more than two decades. Worried about whether she still has what it takes after so much time away, Laurie finds her first case back to be a dangerous puzzler of the highest order, involving organized crime and two start-up biotech companies caught in a zero sum game...." --inside front cover.

Nick Heller, private spy, exposes secrets that powerful people would rather keep hidden. At the funeral of his good friend Sean, an army buddy who once saved Nick's life and had struggled with opioid addiction since returning wounded from war, a stranger approaches Nick with a job. The woman is a member of the Kimball family, whose immense fortune was built on opiates. Now she wants to become a whistleblower, exposing evidence that Kimball Pharmaceutical...

A pharmacy in Kermit, West Virginia, distributed 12 million opioid pain pills in three years to a town with a population of 382 people. Debbie Preece lost her brother to opioid overdose, and was desperate for justice. Joined by a crusading lawyer and a local journalist, they uncovered a massive opioid pill-dumping scandal that shook the foundation of America's largest drug companies-- and won Eyre a Pulitzer Prize. Here Eyre explains how thousands...

"The inside story of how Big Pharma's relentless pursuit of ever-higher profits corrupts medical knowledge, misleading doctors, misdirecting American health care, and harming our health"--Book jacket flap.

"The blistering inside story of a startup that made millions pushing opioids-until its cutthroat tactics were exposed and its executives put behind bars John Kapoor had amassed a small fortune in pharmaceuticals when he conceived of a new product. It was the 2000s, and opioids were big business. If Kapoor, an immigrant and the billionaire founder of Insys, could find a new way to administer the highly potent fentanyl, he could patent his invention...

"Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?...